Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Healthcare/Life Sciences
![Amgen's Deal for Horizon Therapeutics Clears Key Hurdle](http://www.nasdaqpicks.com/wp-content/uploads/2023/09/Amgen039s-Deal-for-Horizon-Therapeutics-Clears-Key-Hurdle-400x400.jpeg)
Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
- By nasdaqpicks.com
- . 1 September 2023
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims
![FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/FTC-Pauses-Challenge-to-Amgen039s-278-Billion-Deal-for-Horizon-400x400.jpeg)
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
- By nasdaqpicks.com
- . 26 August 2023
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
![Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Teva-Agrees-to-Pay-225-Million-to-Settle-US-Price-Fixing-400x400.jpeg)
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
- By nasdaqpicks.com
- . 22 August 2023
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
![Ozempic Settles the Obesity Debate: It's Biology Over Willpower](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Ozempic-Settles-the-Obesity-Debate-It039s-Biology-Over-Willpower-400x400.jpeg)
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
- By nasdaqpicks.com
- . 14 August 2023
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
![Could Scientist Find Drug to Treat His Own Disease?](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Could-Scientist-Find-Drug-to-Treat-His-Own-Disease-400x400.jpeg)
Could Scientist Find Drug to Treat His Own Disease?
- By nasdaqpicks.com
- . 13 August 2023
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-400x400.jpeg)
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
- By nasdaqpicks.com
- . 8 August 2023
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
![Drug Shortages Are a Boon to One Industry: Compounding Pharmacies](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Drug-Shortages-Are-a-Boon-to-One-Industry-Compounding-Pharmacies-400x400.jpeg)
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
- By nasdaqpicks.com
- . 7 August 2023
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
![Efforts to Spotlight Private Equity's Healthcare Stakes Struggle for Traction](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Efforts-to-Spotlight-Private-Equity039s-Healthcare-Stakes-Struggle-for-Traction-400x400.jpeg)
Efforts to Spotlight Private Equity's Healthcare Stakes Struggle for Traction
- By nasdaqpicks.com
- . 6 August 2023
Congress and regulatory agencies have made scant headway in requiring medical companies to reveal owners. Source link
![Pfizer’s Covid Boost Crashes to Earth](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizers-Covid-Boost-Crashes-to-Earth-400x400.jpeg)
Pfizer’s Covid Boost Crashes to Earth
- By nasdaqpicks.com
- . 6 August 2023
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
![First Pill for Postpartum Depression Is Approved by FDA](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/First-Pill-for-Postpartum-Depression-Is-Approved-by-FDA-400x400.jpeg)
First Pill for Postpartum Depression Is Approved by FDA
- By nasdaqpicks.com
- . 5 August 2023
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link